Legal Representation
Attorney
Geza C. Ziegler Jr.
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 27, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Sep 27, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 15, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 15, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 15, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 9, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 9, 2021 | GAUN | O | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | Loading... |
| Feb 9, 2021 | GAUD | O | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | Loading... |
| Feb 9, 2021 | NAUD | R | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | Loading... |
| Jan 13, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 13, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 8, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 30, 2020 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Aug 11, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 11, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 11, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 15, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 1, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 25, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Liquid herbal supplements; Liquid nutritional supplement; Liquid protein supplements; Liquid vitamin supplements; Dietary supplements in the form of liquid to aid and boost the immune system; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005